Investing in unprofitable businesses like biotech and mining exploration can be lucrative, but many companies end up bankrupt due to cash burn. Nuvation Bio (NYSE:NUVB) has a cash runway of 9.3 years, reducing cash burn by 29% last year.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing